RB 5/2023:Incidental violation of information duty specified in Exhibit 3 to the ATS Regulations
Firma: MILESTONE MEDICALSpis treści:
1. RAPORT BIEŻĄCY
2. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| In connection with point 16a of Best Practices of NewConnect Listed Companies, the Board of Directors of Milestone Medical Inc. (the "Company") informs about incidental violation of information duty specified in Exhibit 3 to the Alternative Trading System Rules by the Company. Violation relates to untimely publication of current report concerning the changes in the composition of the Board of Directors that took place in June 28, 2023.<br /> The Company has published today EIB report about the changes in the composition of the Board of Directors. The reason of delay in publishing this report was unintended omission made by the Company. The Board of Directors of the Company will provide necessary actions to ensure that such case will not happen again in the future. Legal basis: Section 4.3 of the Exhibit 3 to the Alternative Trading System Rules "Current and Periodical Information in the Alternative Trading System on the NewConnect Market". |
| Data | Imię i Nazwisko | Stanowisko | Podpis | ||
| 2023-07-06 11:35:53 | Keisha Harcum | Controller |
Cena akcji Milestone
Cena akcji Milestone w momencie publikacji komunikatu to 2.1 PLN. Sprawdź ile kosztuje akcja Milestone aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Milestone.
